Publisher
Springer Nature Switzerland
Reference35 articles.
1. Al-Rashedi NAM, Munahi MG, ALObaidi LA (2020) Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing. J Biomol Struct Dyn 40:1–14. https://doi.org/10.1080/07391102.2020.1863265
2. Anwar F, Altayb HN, Al-Abbasi FA, Kumar V, Kamal MA (2021) The computational intervention of macrolide antibiotics in the treatment of COVID-19. Curr Pharm Des 27(9):1202–1210. https://doi.org/10.2174/1381612827666210125121954
3. Barage S, Karthic A, Bavi R, Desai N, Kumar R, Kumar V, Lee KW (2020) Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach. J Biomol Struct Dyn 40:1–18. https://doi.org/10.1080/07391102.2020.1841026
4. Batool A, Bibi N, Amin F, Kamal MA (2021) Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach. Eur J Pharmacol 892:173779. https://doi.org/10.1016/j.ejphar.2020.173779
5. Canal B, Fujisawa R, McClure AW, Deegan TD, Wu M, Ulferts R, Weissmann F, Drury LS, Bertolin AP, Zeng J, Beale R, Howell M, Labib K, Diffley JFX (2021) Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease. Biochem J 478(13):2465–2479. https://doi.org/10.1042/BCJ20210199